TITLE

Mycobacterium tuberculosis: factores de virulencia

PUB. DATE
January 2011
SOURCE
Revista VacciMonitor (Vacunología y Temas Afines);ene-abr2011, Vol. 20 Issue 1, p34
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
58496689

 

Related Articles

  • LprG-Mediated Surface Expression of Lipoarabinomannan Is Essential for Virulence of Mycobacterium tuberculosis. Gaur, Rajiv L.; Ren, Kangning; Blumenthal, Antje; Bhamidi, Suresh; Gibbs, Sara; Jackson, Mary; Zare, Richard N.; Ehrt, Sabine; Ernst, Joel D.; Banaei, Niaz // PLoS Pathogens;Sep2014, Vol. 10 Issue 9, p1 

    Mycobacterium tuberculosis employs various virulence strategies to subvert host immune responses in order to persist and cause disease. Interaction of M. tuberculosis with mannose receptor on macrophages via surface-exposed lipoarabinomannan (LAM) is believed to be critical for cell entry,...

  • Experimental Cytomorphological Studies of the Reaction of Mononuclear Phagocyte System in Granulomatosis of Mixed (Silicotic and Tuberculous) Etiology. Shkurupy, V.; Nadeev, A.; Karpov, M.; Bugrimova, Yu. // Bulletin of Experimental Biology & Medicine;Apr2010, Vol. 149 Issue 4, p462 

    Silicon dioxide in combination with Mycobacterium tuberculosis in BCG vaccine is characterized by a significantly higher granuloma-inducing activity than BCG or silicon dioxide alone. Cell 'dissociation' from granulomas is not characteristic of granulomas induced by silicon dioxide or its...

  • THE FIFTH-COLUMN EPIDEMIC. Glausiusz, Josie // Discover;Mar2001, Vol. 22 Issue 3, p11 

    Identifies Mycobacterium tuberculosis as a possible causative agent of the influenza pandemic in the United States. Source of data; Action of the bacterium in the lungs; Prevalence of tuberculosis among adults; Risks for the developing countries.

  • Protective Efficacy of BCG Overexpressing an L,DTranspeptidase against M. tuberculosis Infection. Nolan, Scott T.; Lamichhane, Gyanu // PLoS ONE;2010, Vol. 5 Issue 10, p1 

    Background: M. bovis Bacille Calmette-Guérin (BCG), currently the only available vaccine against tuberculosis (TB), fails to adequately protect individuals from active and latent TB infection. New vaccines are desperately needed to decrease the worldwide burden of TB. Methods and Findings: We...

  • Deletion of a Mycobacterium tuberculosis Proteasomal ATPase Homologue Gene Produces a Slow-Growing Strain That Persists in Host Tissues. Lamichhane, Gyanu; Raghunand, Tirumalai R.; Morrison, Norman E.; Woolwine, Samuel C.; Tyagi, Sandeep; Kandavelou, Karthikeyan; Bishai, William R. // Journal of Infectious Diseases;11/1/2006, Vol. 194 Issue 9, p1233 

    The in vivo rate of proliferation of Mycobacterium tuberculosis, the causative agent of tuberculosis, has been linked to the rate of progression and severity of disease. Here, we report that deletion of the gene MT2175 (Rv2115c), a putative mycobacterial proteasome-associated AAA-ATPase, leads...

  • Is multiple sclerosis CNS leprosy? Abokrysha, Noha T. // Iranian Journal of Medical Hypotheses & Ideas;2008, Vol. 2, p1 

    Multiple sclerosis (MS) is widely believed to be an autoimmune disorder. Another exciting idea regarding the aetiology of MS may be that the immune response in MS could result from a chronic infection rather than autoimmunity in the usual sense. M. leprae-induced myelin damage in the early...

  • Contraindicated BCG vaccination in "at risk" infants. Rees, Philippa; Evans, Huw; Panesar, Sukhmeet; Llewelyn, Meirion; Edwards, Adrian; Carson-Stevens, Andrew // BMJ: British Medical Journal;9/13/2014, Vol. 349 Issue 7974, p20 

    A letter to the editor is presented in response to the article "Effect of BCG Vaccination Against Mycobacterium Tuberculosis Infection in Children: Systematic Review and Meta-Analysis" by A. Roy and colleagues in the August 5, 2014 issue.

  • Tuberculosis and bacille-calmette-guerin vaccination.  // MMWR: Morbidity & Mortality Weekly Report;12/26/1997 Supplement RR-18, Vol. 46, p13 

    Focuses on the use of the bacille calmette-guerin (BCG) vaccine for infection with Mycobacterium tuberculosis (TB) in the United States. Reason BCG is not recommended to general use; Strategies for the prevention and control of TB; Information on the role of the BCG vaccination in the...

  • BCG and infection with Mycobacterium tuberculosis. Turner, Richard D.; Tweed, Conor D.; Shukla, Jilna; Bothamley, Graham H.; Michelsen, S. W.; Agger, E. M.; Hoff, S. T.; Soborg, B.; Carstensen, L.; Koch, A.; Lillebaek, T.; Sorensen, H. C. F.; Wohlfahrt, J.; Melbye, M. // Thorax;Mar2015, Vol. 70 Issue 3, p286 

    A letter to editor is presented in response to the article "The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland" by S. W. Michelsen, B. Soborg and colleagues in the 2014 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics